{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:11:50Z","timestamp":1792131110668,"version":"4.4.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2021R1F1A1060970"],"award-info":[{"award-number":["2021R1F1A1060970"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2019R1A2C2004214"],"award-info":[{"award-number":["2019R1A2C2004214"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A6A1A03038899"],"award-info":[{"award-number":["2021R1A6A1A03038899"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1A2C1102386"],"award-info":[{"award-number":["2020R1A2C1102386"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea Healthy Industry Development Institute","award":["HI23C0661"],"award-info":[{"award-number":["HI23C0661"]}]},{"DOI":"10.13039\/501100013490","name":"Daegu-Gyeongbuk Medical Innovation Foundation","doi-asserted-by":"publisher","award":["B-A-H-21-02"],"award-info":[{"award-number":["B-A-H-21-02"]}],"id":[{"id":"10.13039\/501100013490","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00109-024-02428-6","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T22:02:18Z","timestamp":1709157738000},"page":"571-583","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The complement factor H-related protein-5 (CFHR5) exacerbates pathological bone formation in ankylosing spondylitis"],"prefix":"10.1007","volume":"102","author":[{"given":"Ji-Hyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanhyeok","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinil","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeehee","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Jong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Seo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3034-5029","authenticated-orcid":false,"given":"Sungsin","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3542-2276","authenticated-orcid":false,"given":"Tae-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Nam","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"key":"2428_CR1","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/ard.2008.091074","volume":"68","author":"M Benjamin","year":"2009","unstructured":"Benjamin M, Toumi H, Suzuki D, Hayashi K, McGonagle D (2009) Evidence for a distinctive pattern of bone formation in enthesophytes. Ann Rheum Dis 68:1003\u20131010. https:\/\/doi.org\/10.1136\/ard.2008.091074","journal-title":"Ann Rheum Dis"},{"key":"2428_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13075-015-0805-0","volume":"18","author":"HW Tseng","year":"2016","unstructured":"Tseng HW, Pitt ME, Glant TT, McRae AF, Kenna TJ, Brown MA, Pettit AR, Thomas GP (2016) Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes. Arthritis Res Ther 18:35. https:\/\/doi.org\/10.1186\/s13075-015-0805-0","journal-title":"Arthritis Res Ther"},{"key":"2428_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13075-015-0675-5","volume":"17","author":"J Bleil","year":"2015","unstructured":"Bleil J, Sieper J, Maier R, Schlichting U, Hempfing A, Syrbe U, Appel H (2015) Cartilage in facet joints of patients with ankylosing spondylitis (AS) shows signs of cartilage degeneration rather than chondrocyte hypertrophy: implications for joint remodeling in AS. Arthritis Res Ther 17:170. https:\/\/doi.org\/10.1186\/s13075-015-0675-5","journal-title":"Arthritis Res Ther"},{"key":"2428_CR4","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","volume":"13","author":"G Schett","year":"2017","unstructured":"Schett G, Lories RJ, D\u2019Agostino MA, Elewaut D, Kirkham B, Soriano ER, McGonagle D (2017) Enthesitis: from pathophysiology to treatment. Nat Rev Rheumatol 13:731\u2013741. https:\/\/doi.org\/10.1038\/nrrheum.2017.188","journal-title":"Nat Rev Rheumatol"},{"key":"2428_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrrheum.2017.56","volume":"13","author":"V Ranganathan","year":"2017","unstructured":"Ranganathan V, Gracey E, Brown MA, Inman RD, Haroon N (2017) Pathogenesis of ankylosing spondylitis - recent advances and future directions. Nat Rev Rheumatol 13:359\u2013367. https:\/\/doi.org\/10.1038\/nrrheum.2017.56","journal-title":"Nat Rev Rheumatol"},{"key":"2428_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41584-022-00761-z","volume":"18","author":"A Danve","year":"2022","unstructured":"Danve A, Deodhar A (2022) Treatment of axial spondyloarthritis: an update. Nat Rev Rheumatol 18:205\u2013216. https:\/\/doi.org\/10.1038\/s41584-022-00761-z","journal-title":"Nat Rev Rheumatol"},{"key":"2428_CR7","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s10067-015-2949-3","volume":"34","author":"JD Reveille","year":"2015","unstructured":"Reveille JD (2015) Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. Clin Rheumatol 34:1009\u20131018. https:\/\/doi.org\/10.1007\/s10067-015-2949-3","journal-title":"Clin Rheumatol"},{"key":"2428_CR8","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/art.24838","volume":"61","author":"MK de Vries","year":"2009","unstructured":"de Vries MK, van Eijk IC, van der Horst-Bruinsma IE, Peters MJ, Nurmohamed MT, Dijkmans BA, Hazenberg BP, Wolbink GJ (2009) Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis. Arthritis Rheum 61:1484\u20131490. https:\/\/doi.org\/10.1002\/art.24838","journal-title":"Arthritis Rheum"},{"key":"2428_CR9","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.3899\/jrheum.160003","volume":"43","author":"J Braun","year":"2016","unstructured":"Braun J, Baraliakos X, Hermann KG, Xu S, Hsu B (2016) Serum C-reactive protein levels demonstrate predictive value for radiographic and magnetic resonance imaging outcomes in patients with active ankylosing spondylitis treated with golimumab. J Rheumatol 43:1704\u20131712. https:\/\/doi.org\/10.3899\/jrheum.160003","journal-title":"J Rheumatol"},{"key":"2428_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4078\/jrd.2021.28.2.55","volume":"28","author":"RD Inman","year":"2021","unstructured":"Inman RD (2021) Axial spondyloarthritis: current advances, future challenges. J Rheum Dis 28:55\u201359. https:\/\/doi.org\/10.4078\/jrd.2021.28.2.55","journal-title":"J Rheum Dis"},{"key":"2428_CR11","doi-asserted-by":"publisher","first-page":"1759720X2090604","DOI":"10.1177\/1759720X20906040","volume":"12","author":"X Baraliakos","year":"2020","unstructured":"Baraliakos X, Gensler LS, D\u2019Angelo S, Iannone F, Favalli EG, de Peyrecave N, Auteri SE, Caporali R (2020) Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: a structured literature review. Ther Adv Musculoskelet Dis 12:1759720X20906040. https:\/\/doi.org\/10.1177\/1759720X20906040","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2428_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/imr.13166","volume":"313","author":"L Lucientes-Continente","year":"2023","unstructured":"Lucientes-Continente L, Marquez-Tirado B, Goicoechea de Jorge E (2023) The factor H protein family: the switchers of the complement alternative pathway. Immunol Rev 313:25\u201345. https:\/\/doi.org\/10.1111\/imr.13166","journal-title":"Immunol Rev"},{"key":"2428_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1385\/IR:33:2:103","volume":"33","author":"H Rus","year":"2005","unstructured":"Rus H, Cudrici C, Niculescu F (2005) The role of the complement system in innate immunity. Immunol Res 33:103\u2013112. https:\/\/doi.org\/10.1385\/IR:33:2:103","journal-title":"Immunol Res"},{"key":"2428_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01524-6","author":"EE West","year":"2023","unstructured":"West EE, Woodruff T, Fremeaux-Bacchi V, Kemper C (2023) Complement in human disease: approved and up-and-coming therapeutics. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(23)01524-6","journal-title":"Lancet"},{"key":"2428_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/ard.41.1.86","volume":"41","author":"L Brinch","year":"1982","unstructured":"Brinch L, Vinje O, Teisberg P, Mellbye OJ, Aakesson I (1982) The in-vivo metabolism of C3 in ankylosing spondylitis. Ann Rheum Dis 41:86\u201389. https:\/\/doi.org\/10.1136\/ard.41.1.86","journal-title":"Ann Rheum Dis"},{"key":"2428_CR16","first-page":"308","volume":"2","author":"TD Kinsella","year":"1975","unstructured":"Kinsella TD, Espinoza L, Vasey FB (1975) Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis. J Rheumatol 2:308\u2013313","journal-title":"J Rheumatol"},{"key":"2428_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/BF00541327","volume":"5","author":"PB Krauledat","year":"1985","unstructured":"Krauledat PB, Krapf FE, Manger B, Kalden JR (1985) Evaluation of plasma C3d and immune complex determinations in the assessment of disease activity of patients with rheumatoid arthritis, systemic lupus erythematosus, and spondylitis ancylopoetica. Rheumatol Int 5:97\u2013101. https:\/\/doi.org\/10.1007\/BF00541327","journal-title":"Rheumatol Int"},{"key":"2428_CR18","first-page":"201","volume":"28","author":"T Li","year":"2010","unstructured":"Li T, Huang Z, Zheng B, Liao Z, Zhao L, Gu J (2010) Serum disease-associated proteins of ankylosing spondylitis: results of a preliminary study by comparative proteomics. Clin Exp Rheumatol 28:201\u2013207","journal-title":"Clin Exp Rheumatol"},{"key":"2428_CR19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/BF02031273","volume":"3","author":"O Vinje","year":"1984","unstructured":"Vinje O, Moller P, Mellbye J (1984) Immunological variables and acute-phase reactants in patients with ankylosing spondylitis (Bechterew\u2019s syndrome) and their relatives. Clin Rheumatol 3:501\u2013513. https:\/\/doi.org\/10.1007\/BF02031273","journal-title":"Clin Rheumatol"},{"key":"2428_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.smim.2018.01.001","volume":"37","author":"Y Modinger","year":"2018","unstructured":"Modinger Y, Loffler B, Huber-Lang M, Ignatius A (2018) Complement involvement in bone homeostasis and bone disorders. Semin Immunol 37:53\u201365. https:\/\/doi.org\/10.1016\/j.smim.2018.01.001","journal-title":"Semin Immunol"},{"key":"2428_CR21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.imbio.2018.07.023","volume":"223","author":"JJ Alexander","year":"2018","unstructured":"Alexander JJ, Sankaran JS, Seldeen KL, Thiyagarajan R, Jacob A, Quigg RJ, Troen BR, Judex S (2018) Absence of complement factor H alters bone architecture and dynamics. Immunobiology 223:761\u2013771. https:\/\/doi.org\/10.1016\/j.imbio.2018.07.023","journal-title":"Immunobiology"},{"key":"2428_CR22","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1021\/acs.jproteome.9b00676","volume":"19","author":"S Liu","year":"2020","unstructured":"Liu S, Ji W, Lu J, Tang X, Guo Y, Ji M, Xu T, Gu W, Kong D, Shen Q et al (2020) Discovery of potential serum protein biomarkers in ankylosing spondylitis using tandem mass tag-based quantitative proteomics. J Proteome Res 19:864\u2013872. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00676","journal-title":"J Proteome Res"},{"key":"2428_CR23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1136\/ard.39.5.445","volume":"39","author":"GS Panayi","year":"1980","unstructured":"Panayi GS, Slaney J, Williams BD (1980) Circulating immune complexes in patients with ankylosing spondylitis. Ann Rheum Dis 39:445\u2013448. https:\/\/doi.org\/10.1136\/ard.39.5.445","journal-title":"Ann Rheum Dis"},{"key":"2428_CR24","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1136\/ard.45.11.892","volume":"45","author":"E Rodahl","year":"1986","unstructured":"Rodahl E, Iversen OJ (1986) Analysis of circulating immune complexes from patients with ankylosing spondylitis by gel electrophoresis and immunoblotting using antiserum against a psoriasis associated retrovirus-like particle. Ann Rheum Dis 45:892\u2013898. https:\/\/doi.org\/10.1136\/ard.45.11.892","journal-title":"Ann Rheum Dis"},{"key":"2428_CR25","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.molimm.2013.06.001","volume":"56","author":"C Skerka","year":"2013","unstructured":"Skerka C, Chen Q, Fremeaux-Bacchi V, Roumenina LT (2013) Complement factor H related proteins (CFHRs). Mol Immunol 56:170\u2013180. https:\/\/doi.org\/10.1016\/j.molimm.2013.06.001","journal-title":"Mol Immunol"},{"key":"2428_CR26","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","volume":"344","author":"MJ Walport","year":"2001","unstructured":"Walport MJ (2001) Complement. First of two parts. N Engl J Med 344:1058\u20131066. https:\/\/doi.org\/10.1056\/NEJM200104053441406","journal-title":"N Engl J Med"},{"key":"2428_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12014-020-09281-y","volume":"17","author":"JH Lee","year":"2020","unstructured":"Lee JH, Jung JH, Kim J, Baek WK, Rhee J, Kim TH, Kim SH, Kim KP, Son CN, Kim JS (2020) Proteomic analysis of human synovial fluid reveals potential diagnostic biomarkers for ankylosing spondylitis. Clin Proteomics 17:20. https:\/\/doi.org\/10.1186\/s12014-020-09281-y","journal-title":"Clin Proteomics"},{"key":"2428_CR28","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1681\/ASN.2015020212","volume":"27","author":"Q Chen","year":"2016","unstructured":"Chen Q, Manzke M, Hartmann A, Buttner M, Amann K, Pauly D, Wiesener M, Skerka C, Zipfel PF (2016) Complement factor H-related 5-hybrid proteins anchor properdin and activate complement at self-surfaces. J Am Soc Nephrol 27:1413\u20131425. https:\/\/doi.org\/10.1681\/ASN.2015020212","journal-title":"J Am Soc Nephrol"},{"key":"2428_CR29","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.4049\/jimmunol.174.10.6250","volume":"174","author":"JL McRae","year":"2005","unstructured":"McRae JL, Duthy TG, Griggs KM, Ormsby RJ, Cowan PJ, Cromer BA, McKinstry WJ, Parker MW, Murphy BF, Gordon DL (2005) Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein. J Immunol 174:6250\u20136256. https:\/\/doi.org\/10.4049\/jimmunol.174.10.6250","journal-title":"J Immunol"},{"key":"2428_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.845953","volume":"13","author":"A Papp","year":"2022","unstructured":"Papp A, Papp K, Uzonyi B, Cserhalmi M, Csincsi AI, Szabo Z, Banlaki Z, Ermert D, Prohaszka Z, Erdei A et al (2022) Complement factor H-related proteins FHR1 and FHR5 interact with extracellular matrix ligands, reduce factor H regulatory activity and enhance complement activation. Front Immunol 13:845953. https:\/\/doi.org\/10.3389\/fimmu.2022.845953","journal-title":"Front Immunol"},{"key":"2428_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368. https:\/\/doi.org\/10.1002\/art.1780270401","journal-title":"Arthritis Rheum"},{"key":"2428_CR32","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1089\/ten.TEA.2009.0105","volume":"16","author":"T Yoshii","year":"2010","unstructured":"Yoshii T, Sotome S, Torigoe I, Maehara H, Sugata Y, Yamada T, Shinomiya K, Okawa A (2010) Isolation of osteogenic progenitor cells from trabecular bone for bone tissue engineering. Tissue Eng Part A 16:933\u2013942. https:\/\/doi.org\/10.1089\/ten.TEA.2009.0105","journal-title":"Tissue Eng Part A"},{"key":"2428_CR33","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1093\/rheumatology\/keaa846","volume":"60","author":"S Jo","year":"2021","unstructured":"Jo S, Won EJ, Kim MJ, Lee YJ, Jin SH, Park PR, Song HC, Kim J, Choi YD, Kim JY et al (2021) STAT3 phosphorylation inhibition for treating inflammation and new bone formation in ankylosing spondylitis. Rheumatology (Oxford) 60:3923\u20133935. https:\/\/doi.org\/10.1093\/rheumatology\/keaa846","journal-title":"Rheumatology (Oxford)"},{"key":"2428_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13075-018-1582-3","volume":"20","author":"S Jo","year":"2018","unstructured":"Jo S, Wang SE, Lee YL, Kang S, Lee B, Han J, Sung IH, Park YS, Bae SC, Kim TH (2018) IL-17A induces osteoblast differentiation by activating JAK2\/STAT3 in ankylosing spondylitis. Arthritis Res Ther 20:115. https:\/\/doi.org\/10.1186\/s13075-018-1582-3","journal-title":"Arthritis Res Ther"},{"key":"2428_CR35","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4078\/jrd.2021.28.4.216","volume":"28","author":"S Jo","year":"2021","unstructured":"Jo S, Nam B, Lee YL, Park H, Weon S, Choi SH, Park YS, Kim TH (2021) The TNF-NF-kB-DKK1 axis promoted bone formation in the enthesis of ankylosing spondylitis. J Rheum Dis 28:216\u2013224. https:\/\/doi.org\/10.4078\/jrd.2021.28.4.216","journal-title":"J Rheum Dis"},{"key":"2428_CR36","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nature02119","volume":"426","author":"N Sakaguchi","year":"2003","unstructured":"Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, Sakihama T, Matsutani T, Negishi I, Nakatsuru S et al (2003) Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426:454\u2013460. https:\/\/doi.org\/10.1038\/nature02119","journal-title":"Nature"},{"key":"2428_CR37","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1002\/art.34423","volume":"64","author":"M Ruutu","year":"2012","unstructured":"Ruutu M, Thomas G, Steck R, Degli-Esposti MA, Zinkernagel MS, Alexander K, Velasco J, Strutton G, Tran A, Benham H et al (2012) Beta-glucan triggers spondylarthritis and Crohn\u2019s disease-like ileitis in SKG mice. Arthritis Rheum 64:2211\u20132222. https:\/\/doi.org\/10.1002\/art.34423","journal-title":"Arthritis Rheum"},{"key":"2428_CR38","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/art.38638","volume":"66","author":"H Benham","year":"2014","unstructured":"Benham H, Rehaume LM, Hasnain SZ, Velasco J, Baillet AC, Ruutu M, Kikly K, Wang R, Tseng HW, Thomas GP et al (2014) Interleukin-23 mediates the intestinal response to microbial beta-1,3-glucan and the development of spondyloarthritis pathology in SKG mice. Arthritis Rheumatol 66:1755\u20131767. https:\/\/doi.org\/10.1002\/art.38638","journal-title":"Arthritis Rheumatol"},{"key":"2428_CR39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/jbmr.4751","volume":"38","author":"S Jo","year":"2023","unstructured":"Jo S, Lee SH, Park J, Nam B, Kim H, Youn J, Lee S, Kim TJ, Sung IH, Choi SH et al (2023) Platelet-derived growth factor B is a key element in the pathological bone formation of ankylosing spondylitis. J Bone Miner Res 38:300\u2013312. https:\/\/doi.org\/10.1002\/jbmr.4751","journal-title":"J Bone Miner Res"},{"key":"2428_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.660852","volume":"12","author":"E Karpati","year":"2021","unstructured":"Karpati E, Kremlitzka M, Sandor N, Hajnal D, Schneider AE, Jozsi M (2021) Complement factor H family proteins modulate monocyte and neutrophil granulocyte functions. Front Immunol 12:660852. https:\/\/doi.org\/10.3389\/fimmu.2021.660852","journal-title":"Front Immunol"},{"key":"2428_CR41","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1016\/j.molimm.2010.05.007","volume":"47","author":"VP Ferreira","year":"2010","unstructured":"Ferreira VP, Pangburn MK, Cortes C (2010) Complement control protein factor H: the good, the bad, and the inadequate. Mol Immunol 47:2187\u20132197. https:\/\/doi.org\/10.1016\/j.molimm.2010.05.007","journal-title":"Mol Immunol"},{"key":"2428_CR42","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.joca.2021.11.013","volume":"30","author":"S Jo","year":"2022","unstructured":"Jo S, Lee JS, Nam B, Lee YL, Kim H, Lee EY, Park YS, Kim TH (2022) SOX9(+) enthesis cells are associated with spinal ankylosis in ankylosing spondylitis. Osteoarthritis Cartilage 30:280\u2013290. https:\/\/doi.org\/10.1016\/j.joca.2021.11.013","journal-title":"Osteoarthritis Cartilage"},{"key":"2428_CR43","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1002\/art.39715","volume":"68","author":"J Bleil","year":"2016","unstructured":"Bleil J, Maier R, Hempfing A, Sieper J, Appel H, Syrbe U (2016) Granulation tissue eroding the subchondral bone also promotes new bone formation in ankylosing spondylitis. Arthritis Rheumatol 68:2456\u20132465. https:\/\/doi.org\/10.1002\/art.39715","journal-title":"Arthritis Rheumatol"},{"key":"2428_CR44","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0092-8674(92)90598-7","volume":"71","author":"AC Chan","year":"1992","unstructured":"Chan AC, Iwashima M, Turck CW, Weiss A (1992) ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell 71:649\u2013662. https:\/\/doi.org\/10.1016\/0092-8674(92)90598-7","journal-title":"Cell"},{"key":"2428_CR45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1084\/jem.20150888","volume":"213","author":"AY Chan","year":"2016","unstructured":"Chan AY, Punwani D, Kadlecek TA, Cowan MJ, Olson JL, Mathes EF, Sunderam U, Fu SM, Srinivasan R, Kuriyan J et al (2016) A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70. J Exp Med 213:155\u2013165. https:\/\/doi.org\/10.1084\/jem.20150888","journal-title":"J Exp Med"},{"key":"2428_CR46","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/376435a0","volume":"376","author":"I Negishi","year":"1995","unstructured":"Negishi I, Motoyama N, Nakayama K, Nakayama K, Senju S, Hatakeyama S, Zhang Q, Chan AC, Loh DY (1995) Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature 376:435\u2013438. https:\/\/doi.org\/10.1038\/376435a0","journal-title":"Nature"},{"key":"2428_CR47","doi-asserted-by":"publisher","first-page":"eabg1210","DOI":"10.1126\/scitranslmed.abg1210","volume":"13","author":"A Nakamura","year":"2021","unstructured":"Nakamura A, Zeng F, Nakamura S, Reid KT, Gracey E, Lim M, Leng L, Jo S, Park YS, Kusuda M et al (2021) Macrophage migration inhibitory factor drives pathology in a mouse model of spondyloarthritis and is associated with human disease. Sci Transl Med 13:eabg1210. https:\/\/doi.org\/10.1126\/scitranslmed.abg1210","journal-title":"Sci Transl Med"},{"key":"2428_CR48","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3389\/fimmu.2020.01123","volume":"11","author":"X Li","year":"2020","unstructured":"Li X, Hao Z, Liu X, Li W (2020) Deficiency of mouse FHR-1 homolog, FHR-E, accelerates sepsis, and acute kidney injury through enhancing the LPS-induced alternative complement pathway. Front Immunol 11:1123. https:\/\/doi.org\/10.3389\/fimmu.2020.01123","journal-title":"Front Immunol"},{"key":"2428_CR49","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.imbio.2019.03.005","volume":"224","author":"X Hu","year":"2019","unstructured":"Hu X, Liu H, Du J, Chen Y, Yang M, Xie Y, Chen J, Yan S, Ouyang S, Gong Z (2019) The clinical significance of plasma CFHR 1\u20135 in lupus nephropathy. Immunobiology 224:339\u2013346. https:\/\/doi.org\/10.1016\/j.imbio.2019.03.005","journal-title":"Immunobiology"},{"key":"2428_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002079","volume":"7","author":"J Zhao","year":"2011","unstructured":"Zhao J, Wu H, Khosravi M, Cui H, Qian X, Kelly JA, Kaufman KM, Langefeld CD, Williams AH, Comeau ME et al (2011) Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet 7:e1002079. https:\/\/doi.org\/10.1371\/journal.pgen.1002079","journal-title":"PLoS Genet"},{"key":"2428_CR51","doi-asserted-by":"publisher","unstructured":"Malik TH, Gitterman DP, Lavin DP, Lomax-Browne HJ, Hiemeyer EC, Moran LB, Boroviak K, Cook HT, Gilmore AC, Mandwie M et al (2021) Gain-of-function factor H-related 5 protein impairs glomerular complement regulation resulting in kidney damage. Proc Natl Acad Sci USA 118.\u00a0https:\/\/doi.org\/10.1073\/pnas.2022722118","DOI":"10.1073\/pnas.2022722118"},{"key":"2428_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.720183","volume":"12","author":"N Garam","year":"2021","unstructured":"Garam N, Cserhalmi M, Prohaszka Z, Szilagyi A, Veszeli N, Szabo E, Uzonyi B, Ilias A, Aigner C, Schmidt A et al (2021) FHR-5 serum levels and CFHR5 genetic variations in patients with immune complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathy. Front Immunol 12:720183. https:\/\/doi.org\/10.3389\/fimmu.2021.720183","journal-title":"Front Immunol"},{"key":"2428_CR53","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/jmg.2005.038315","volume":"43","author":"MA Abrera-Abeleda","year":"2006","unstructured":"Abrera-Abeleda MA, Nishimura C, Smith JL, Sethi S, McRae JL, Murphy BF, Silvestri G, Skerka C, Jozsi M, Zipfel PF et al (2006) Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J Med Genet 43:582\u2013589. https:\/\/doi.org\/10.1136\/jmg.2005.038315","journal-title":"J Med Genet"},{"key":"2428_CR54","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s40620-013-0008-1","volume":"27","author":"N Besbas","year":"2014","unstructured":"Besbas N, Gulhan B, Gucer S, Korkmaz E, Ozaltin F (2014) A novel CFHR5 mutation associated with C3 glomerulonephritis in a Turkish girl. J Nephrol 27:457\u2013460. https:\/\/doi.org\/10.1007\/s40620-013-0008-1","journal-title":"J Nephrol"},{"key":"2428_CR55","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1001\/jamaophthalmol.2021.6072","volume":"140","author":"S Schmitz-Valckenberg","year":"2022","unstructured":"Schmitz-Valckenberg S, Fleckenstein M, Zouache MA, Pfau M, Pappas C, Hageman JL, Agron E, Malley C, Keenan TDL, Chew EY et al (2022) Progression of age-related macular degeneration among individuals homozygous for risk alleles on chromosome 1 (CFH-CFHR5) or chromosome 10 (ARMS2\/HTRA1) or both. JAMA Ophthalmol 140:252\u2013260. https:\/\/doi.org\/10.1001\/jamaophthalmol.2021.6072","journal-title":"JAMA Ophthalmol"},{"key":"2428_CR56","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/jha2.288","volume":"2","author":"S Menotti","year":"2021","unstructured":"Menotti S, Donini M, Pessolano G, Tiro L, Cantini M, Croce J, Morandi M, Mazzi F, Donadello K, Olivieri O et al (2021) Atypical hemolytic uremic syndrome: unique clinical presentation linked to rare CFHR5 mutation. EJHaem 2:838\u2013841. https:\/\/doi.org\/10.1002\/jha2.288","journal-title":"EJHaem"},{"key":"2428_CR57","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/nbt1342","volume":"25","author":"D Ricklin","year":"2007","unstructured":"Ricklin D, Lambris JD (2007) Complement-targeted therapeutics. Nat Biotechnol 25:1265\u20131275. https:\/\/doi.org\/10.1038\/nbt1342","journal-title":"Nat Biotechnol"},{"key":"2428_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13075-023-03044-4","volume":"25","author":"M Hwang","year":"2023","unstructured":"Hwang M, Assassi S, Zheng J, Castillo J, Chavez R, Vanarsa K, Mohan C, Reveille J (2023) Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitis. Arthritis Res Ther 25:57. https:\/\/doi.org\/10.1186\/s13075-023-03044-4","journal-title":"Arthritis Res Ther"},{"key":"2428_CR59","doi-asserted-by":"publisher","DOI":"10.4110\/in.2021.21.e45","volume":"21","author":"VM Holers","year":"2021","unstructured":"Holers VM, La Rosa FG, Banda NK (2021) A potential new mouse model of axial spondyloarthritis involving the complement system. Immune Netw 21:e45. https:\/\/doi.org\/10.4110\/in.2021.21.e45","journal-title":"Immune Netw"},{"key":"2428_CR60","doi-asserted-by":"publisher","first-page":"34643","DOI":"10.1038\/srep34643","volume":"6","author":"C Yang","year":"2016","unstructured":"Yang C, Ding P, Wang Q, Zhang L, Zhang X, Zhao J, Xu E, Wang N, Chen J, Yang G et al (2016) Inhibition of complement retards ankylosing spondylitis progression. Sci Rep 6:34643. https:\/\/doi.org\/10.1038\/srep34643","journal-title":"Sci Rep"},{"key":"2428_CR61","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/art.33465","volume":"64","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy D, Haibel H, Listing J, Marker-Hermann E, Zeidler H, Braun J, Sieper J, Rudwaleit M (2012) Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 64:1388\u20131398. https:\/\/doi.org\/10.1002\/art.33465","journal-title":"Arthritis Rheum"},{"key":"2428_CR62","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1038\/s41467-023-38383-y","volume":"14","author":"MJ Iglesias","year":"2023","unstructured":"Iglesias MJ, Sanchez-Rivera L, Ibrahim-Kosta M, Naudin C, Munsch G, Goumidi L, Farm M, Smith PM, Thibord F, Kral-Pointner JB et al (2023) Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism. Nat Commun 14:3280. https:\/\/doi.org\/10.1038\/s41467-023-38383-y","journal-title":"Nat Commun"},{"key":"2428_CR63","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2010.79","volume":"6","author":"LS Tam","year":"2010","unstructured":"Tam LS, Gu J, Yu D (2010) Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol 6:399\u2013405. https:\/\/doi.org\/10.1038\/nrrheum.2010.79","journal-title":"Nat Rev Rheumatol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-024-02428-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-024-02428-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-024-02428-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T02:07:18Z","timestamp":1711332438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-024-02428-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["2428"],"URL":"https:\/\/doi.org\/10.1007\/s00109-024-02428-6","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,29]]},"assertion":[{"value":"18 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University Hanyang University Hospital (2014\u201305-002) and approved by the Animals Ethics Screening Committee of Hanyang University (2021-0229A).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Ji-Hyun Lee and Jinil Han are employed by Rheumarker Bio Inc. and Gencurix Inc., respectively. Chang-Nam Son is the chief executive officer (CEO) of Rheumarker Bio Inc. Other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}